Dr. Reddy’s Laboratories (NSE: DRREDDY), an internationally renowned pharmaceutical corporation with its main operations in India, announced on June 23 that it’s expanding into the Indian trade generics industry by unveiling a novel business unit, RGenX. Initially, the company’s trade generics line will target products intended for acute care. The business model, relying heavily on […]
